
Core Scientific Shareholders Reject $9B CoreWeave Deal
CoreWeave terminated its $9 billion all-stock merger with Core Scientific after shareholders rejected the deal, leading to a decline in CoreWeave's stock. The deal's rejection reflects ongoing investor caution despite the growing AI cloud market, with CoreWeave continuing to operate its data centers and serve major clients like OpenAI and Microsoft.












